care setting by Knowlton [1] in this issue of the Journal of Intensive Care Medicine is timely and valuable. Importantly, the author emphasizes acute adrenal insufficiency in the course of, or following, antiinflammatory steroid therapy and the emerging constellation of both primary and possibly secondary adrenal failure associated with the acquired immunodeficiency syndrome (AIDS).
The comprehensive review of adrenal insufficiency in an intensive care setting by Knowlton [1] in this issue of the Journal of Intensive Care Medicine is timely and valuable. Importantly, the author emphasizes acute adrenal insufficiency in the course of, or following, antiinflammatory steroid therapy and the emerging constellation of both primary and possibly secondary adrenal failure associated with the acquired immunodeficiency syndrome (AIDS).
It is estimated that 8 to 10 million patients are treated with corticosteroids each year. Suppression of the hypothalamic-pituitary-adrenal system is among the more prevalent and potentially hazardous derangements produced by corticosteroids. In a series of postmortem examinations, Salassa and colleagues [2] demonstrated a reduction in adrenal gland weight after 10 days of high-dose corticosteroid therapy. Some degree of adrenal atrophy is apparent in nearly all species tested after 10 days of high-dose corticosteroid administration. This atrophy appears to be completely reversible. In a number of studies, feedback inhibition of adrenocorticotropic hormone (ACTH) and cortisol secretory activity is interfered with for a period of 12 months after as short a period as 2 weeks of highdose steroid therapy; stress responsiveness in the pituitary and the adrenal glands may be recovered much earlier. I have examined the adrenal response to pyrogen stress in relation to the duration and dose of steroids, as well as length of time after cessation of therapy [3] . I found that daily doses of less than 20 mg of cortisol or equipotent doses of its synthetic analogues in combination with cessation of corticosteroid therapy for a period of 5 months or more are associated with normal pyrogen stress responsiveness. Thus, acute adrenal insufficiency in these patients is unlikely to develop. Similarly, patients receiving alternate-day steroid therapy had little or no attenuation of pyrogen stress response. Most patients receiving 50 mg cortisol or equipotent doses of its synthetic analogues had little response to pyrogen stress 1 month after cessation of steroid therapy regardless of whether it had been continued for one month or for eight years. Any patient who has received daily corticosteroid therapy up to 6 months before arriving in an intensive care unit should receive adrenocorticol replacement therapy.
Approximately 5% of patients with AIDS studied at the San Francisco General Hospital have the clinical and biochemical findings of acute adrenal insufficiency [Biglieri EG. Personal communication, 1988]. Fifty percent of all patients with AIDS exhibit hyporesponsiveness to injected ACTH in terms of cortisol secretory activity. However, aldosterone production remains normal because adrenalitis secondary to cytomegalovirus, mycobacterial, or fungal infection spares the zona glomerulosez. Thus, hyperkalemia is not a prominent manifestation of adrenal insufficiency associated with AIDS. Because ACTH levels do not increase, and because other steroid pathways appear to be selectively altered in AIDS, Membreno and co-workers [4] have suggested that AIDS encephalitis, basilar meningitis, or autoimmune hypophysitis might be responsible for the initial alterations in hypothalamic-pituitary-adrenocortical function. Patients with AIDS who present with circulatory failure require high-dose replacement therapy of cortisol and chronic replacement doses after the acute prostrating illness subsides. Replacement doses do not enhance the spread of opportunistic infections.
It is probable that AIDS will rapidly become the most common cause of acute adrenal insufficiency if 5% of all patients are affected.
In circulatory failure accompanying acute adrenal insufficiency, only glucocorticoids restore circulatory competence because the corticosteroids, as opposed to aldosterone, exhibit an inotropic effect on the myocardium, which possesses receptors with a high affinity for the corticosteroids.
Glucocorticoid receptors have been demonstrated
in the cytosol in the myocardium of a number of species, but cytoplasmic receptors for mineralocorticoids are absent [5] . Postural hypotension is a hallmark of chronic adrenocortical insufficiency (Addi-son's disease). Prolonged deprivation from cortisol actually reduces myocardial weight. A reduction in the weight of the myocardium is a product of both chronic hypovolemia and reduced cardiac output caused by diminished myocardial contractility. Several years ago it was not uncommon to identify patients with Addison's disease by the failure to project a cardiac shadow on anteroposterior radiograms. The microcardia of Addison's disease is completely reversible with steroid replacement therapy. It is likely that normal cortisol concentrations in the extracellular fluid function as a type of &dquo;physiological digitalis.&dquo; Administration of dexamethasone to dogs with severe low cardiac output syndrome results in a 50% decrease in mortality and improvement in cardiac function. Restoration of circulation with antiinflammatory corticosteroids in vascular collapse associated with acute adrenal insufficiency is due in large part to an increase in cardiac output and overall improvement in cardiac function. In patients with circulatory failure in whom any cause of adrenal insufficiency is suspected, intravenously administered soluble corticosteroid esters should be given immediately in doses comparable to the maximal secretory activity of the adrenal cortex under persistent ACTH stimulation. Because of the urgency, it is often necessary to treat patients without a confirmed diagnosis of adrenocortical insufficiency. A bolus of 100 to 200 mg of cortisol as the cortisol phosphate or succi-nate ester should be administered intravenously, and an infusion of soluble cortisol administered at a rate of 15 mg/hr for the first 24 hours, with saline as the vehicle. Restoration of blood pressure may be apparent within minutes and should be complete after 1 hour.
